The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(Dimethylamino)-3,5-dinitro-N-(2,4-dinitrophenyl)benzamide ID: ALA4461207
PubChem CID: 155528284
Max Phase: Preclinical
Molecular Formula: C15H12N6O9
Molecular Weight: 420.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)c1c([N+](=O)[O-])cc(C(=O)Nc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C15H12N6O9/c1-17(2)14-12(20(27)28)5-8(6-13(14)21(29)30)15(22)16-10-4-3-9(18(23)24)7-11(10)19(25)26/h3-7H,1-2H3,(H,16,22)
Standard InChI Key: WLYCWJNLWHWBKM-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 31 0 0 0 0 0 0 0 0999 V2000
3.3127 -18.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3116 -19.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0196 -20.1147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7293 -19.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7265 -18.8826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0179 -18.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4326 -18.4713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1419 -18.8772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4296 -17.6541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0194 -20.9319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3116 -21.3403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7271 -21.3406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6049 -18.4777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6047 -17.6605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8973 -18.8865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8480 -18.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5557 -18.8753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2614 -18.4647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2588 -17.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5445 -17.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8418 -17.6538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5568 -19.6925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8496 -20.1020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2650 -20.1002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9644 -17.2345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6742 -17.6394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9602 -16.4173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6036 -20.1137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8962 -19.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6029 -20.9309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
3 10 1 0
10 11 1 0
10 12 2 0
1 13 1 0
13 14 1 0
13 15 2 0
8 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 22 1 0
22 23 2 0
22 24 1 0
19 25 1 0
25 26 2 0
25 27 1 0
2 28 1 0
28 29 1 0
28 30 1 0
M CHG 8 10 1 11 -1 13 1 14 -1 22 1 24 -1 25 1 27 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.29Molecular Weight (Monoisotopic): 420.0666AlogP: 2.64#Rotatable Bonds: 7Polar Surface Area: 204.90Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 15HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.24CX Basic pKa: ┄CX LogP: 2.93CX LogD: 2.93Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: -1.36
References 1. Güngör T, Önder FC, Tokay E, Gülhan ÜG, Hacıoğlu N, Tok TT, Çelik A, Köçkar F, Ay M.. (2019) PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells., 171 [PMID:30928710 ] [10.1016/j.ejmech.2019.03.035 ]